Abstract
Stem cell therapy and regenerative medicine have a tremendous potential for the treatment of a wide variety of currently fatal diseases. So far, routine stem cell based therapies are limited to the treatment of hematologic and dermatologic malignancies, but the field is continuously evolving. One research focus lies on mesenchymal stem cells (MSCs) which have an immunomodulatory potential and support regenerative processes throughout the body. Pluripotent stem cells, on the other hand, can be differentiated into every cell type and might be able to replace damaged tissue in the future. Currently, stem cell based clinical trials are ongoing for a broad range of diseases affecting every organ, and the number of therapies that are obtaining approval, at least in certain countries, is continuously increasing. In this chapter we summarize the current state of research regarding stem cell based therapies. We introduce stem cell sources along with selected indications for their use and relevant clinical trials. We discuss options as well as limitations and risks of these treatments.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References and Further Reading
Abati E, Bresolin N, Comi GP, Corti S (2019) Preconditioning and cellular engineering to increase the survival of transplanted neural stem cells for motor neuron disease therapy. Mol Neurobiol 56(5):3356–3367. https://doi.org/10.1007/s12035-018-1305-4
Abu-Dawud R, Graffmann N, Ferber S, Wruck W, Adjaye J (2018) Pluripotent stem cells: induction and self-renewal. Philos Trans R Soc Lond Ser B Biol Sci 373(1750). https://doi.org/10.1098/rstb.2017.0213
alliancerm.org. https://alliancerm.org/available-products/. Accessed 18 Sept 2019
Al-Saif AM (2019) Gene therapy of hematological disorders: current challenges. Gene Ther. https://doi.org/10.1038/s41434-019-0093-4
Altman J, Das GD (1965) Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 124:319–335. https://doi.org/10.1002/cne.901240303
Antony PMA, Diederich NJ, Krüger R, Balling R (2013) The hallmarks of Parkinson’s disease. FEBS J 280:5981–5993. https://doi.org/10.1111/febs.12335
Ascheim DD, Gelijns AC, Goldstein D, Moye LA, Smedira N, Lee S, Klodell CT, Szady A, Parides MK, Jeffries NO, Skerrett D, Taylor DA, Rame JE, Milano C, Rogers JG, Lynch J, Dewey T, Eichhorn E, Sun B, Feldman D, Simari R, O’Gara PT, Taddei-Peters WC, Miller MA, Naka Y, Bagiella E, Rose EA, Woo YJ (2014) Mesenchymal Precursor Cells as Adjunctive Therapy in Recipients of Contemporary Left Ventricular Assist Devices. Circulation 129 (22):2287–2296.
Ballen KK, Verter F, Kurtzberg J (2015) Umbilical cord blood donation: public or private? Bone Marrow Transplant 50(10):1271–1278. https://doi.org/10.1038/bmt.2015.124
Barker RA, Drouin-Ouellet J, Parmar M (2015) Cell-based therapies for Parkinson disease – past insights and future potential. Nat Rev Neurol 11:492–503. https://doi.org/10.1038/nrneurol.2015.123
Barker RA, Farrell K, Valle Guzman N, He X, Lazic SE, Moore S, Morris R, Tyers P, Wijeyekoon R, Daft D, Hewitt S, Dayal V, Foltynie T, Kefalopoulou Z, Mahlknecht P, Lao-Kaim NP, Piccini P, Bjartmarz H, Björklund A, Lindvall O, Nelander-Wahlestedt J, Parmar M, Paul G, Widner H, Church A, Dunnett S, Peall K, Rosser A, Marc Gurruchaga J, Palfi S, Piroth T, Winkler C (2019) Designing stem-cell-based dopamine cell replacement trials for Parkinson’s disease. Nat Med 2:1045–1053. https://doi.org/10.1038/s41591-019-0507-2
Barrandon Y, Green H (1987) Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci U S A 84(8):2302–2306. https://doi.org/10.1073/pnas.84.8.2302
Bauer JW, Koller J, Murauer EM, De Rosa L, Enzo E, Carulli S, Bondanza S, Recchia A, Muss W, Diem A, Mayr E, Schlager P, Gratz IK, Pellegrini G, De Luca M (2017) Closure of a large chronic wound through transplantation of gene-corrected epidermal stem cells. J Invest Dermatol 137(3):778–781. https://doi.org/10.1016/j.jid.2016.10.038
Ben M’Barek K, Monville C (2019) Cell therapy for retinal dystrophies: from cell suspension formulation to complex retinal tissue bioengineering. Stem Cells Int 2019:1–14. https://doi.org/10.1155/2019/4568979
Caplan AI (1991) Mesenchymal stem cells. J Orthop Res 9(5):641–650. https://doi.org/10.1002/jor.1100090504
Caplan H, Olson SD, Kumar A, George M, Prabhakara KS, Wenzel P, Bedi S, Toledano-Furman NE, Triolo F, Kamhieh-Milz J, Moll G, Cox CS Jr (2019) Mesenchymal stromal cell therapeutic delivery: translational challenges to clinical application. Front Immunol 10:1645. https://doi.org/10.3389/fimmu.2019.01645
Chagastelles PC, Nardi NB (2011) Biology of stem cells: an overview. Kidney Int Suppl 1(3):63–67. https://doi.org/10.1038/kisup.2011.15
Champlin R (2003) Selection of autologous or allogeneic transplantation. In: Holland-Frei cancer medicine, vol 6. BC Decker, Hamilton
Cho J, D’Antuono M, Glicksman M, Wang J, Jonklaas J (2018) A review of clinical trials: mesenchymal stem cell transplant therapy in type 1 and type 2 diabetes mellitus. Am J Stem Cells 7(4):82–93
Cofano F, Boido M, Monticelli M, Zenga F, Ducati A, Vercelli A, Garbossa D (2019) Mesenchymal stem cells for spinal cord injury: current options, limitations, and future of cell therapy. Int J Mol Sci 20:2698. https://doi.org/10.3390/ijms20112698
Comella K, Parlo M, Daly R, Dominessy K (2018) First-in-man intravenous implantation of stromal vascular fraction in psoriasis: a case study. Int Med Case Rep J 11:59–64. https://doi.org/10.2147/IMCRJ.S163612
Connor B (2018) Concise review: the use of stem cells for understanding and treating Huntington’s disease. Stem Cells 36:146–160. https://doi.org/10.1002/stem.2747
Csobonyeiova M, Polak S, Zamborsky R, Danisovic L (2019) Recent Progress in the regeneration of spinal cord injuries by induced pluripotent stem cells. Int J Mol Sci 20:3838. https://doi.org/10.3390/ijms20153838
Di WL, Lwin SM, Petrova A, Bernadis C, Syed F, Farzaneh F, Moulding D, Martinez AE, Sebire NJ, Rampling D, Virasami A, Zamiri M, Wang W, Hara H, Kadiyirire T, Abdul-Wahab A, Martinez-Queipo M, Harper JI, McGrath JA, Thrasher AJ, Mellerio JE, Qasim W (2019) Generation and clinical application of gene-modified autologous epidermal sheets in netherton syndrome: lessons learned from a phase 1 trial. Hum Gene Ther. https://doi.org/10.1089/hum.2019.049
Diabetes Facts & Figures (2019) International Diabetes Federation. https://www.idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html. Accessed 5 Aust 2019
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315–317. https://doi.org/10.1080/14653240600855905
Dowse R, McLornan DP (2017) Principles of haemopoietic stem cell transplantation. Medicine 45(5):322–326. https://doi.org/10.1016/j.mpmed.2017.02.009
Elstner A, Damaschun A, Kurtz A, Stacey G, Aran B, Veiga A, Borstlap J (2009) The changing landscape of European and international regulation on embryonic stem cell research. Stem Cell Res 2(2):101–107. https://doi.org/10.1016/j.scr.2008.10.003
Fitzsimmons REB, Mazurek MS, Soos A, Simmons CA (2018) Mesenchymal stromal/stem cells in regenerative medicine and tissue engineering. Stem Cells Int 2018:8031718. https://doi.org/10.1155/2018/8031718
Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3(4)
Frobel J, Hemeda H, Lenz M, Abagnale G, Joussen S, Denecke B, Saric T, Zenke M, Wagner W (2014) Epigenetic rejuvenation of mesenchymal stromal cells derived from induced pluripotent stem cells. Stem Cell Rep 3(3):414–422. https://doi.org/10.1016/j.stemcr.2014.07.003
Galipeau J, Sensebe L (2018) Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell 22(6):824–833. https://doi.org/10.1016/j.stem.2018.05.004
GBD 2016, Traumatic Brain Injury and Spinal Cord Injury Collaborators SL, Theadom A, Ellenbogen RG, Bannick MS, Montjoy-Venning W, Lucchesi LR, Abbasi N, Abdulkader R, Abraha HN, Adsuar JC, Afarideh M, Agrawal S, Ahmadi A, Ahmed MB, Aichour AN, Aichour I, Aichour MTE, Akinyemi RO, Akseer N, Alahdab F, Alebel A, Alghnam SA, Ali BA, Alsharif U, Altirkawi K, Andrei CL, Anjomshoa M, Ansari H, Ansha MG, Antonio CAT, Appiah SCY, Ariani F, Asefa NG, Asgedom SW, Atique S, Awasthi A, Quintanilla BPA, Ayuk TB, Azzopardi PS, Badali H, Badawi A, Balalla S, Banstola A, Barker-Collo SL, Bärnighausen TW, Bedi N, Behzadifar M, Behzadifar M, Bekele BB, Belachew AB, Belay YA, Bennett DA, Bensenor IM, Berhane A, Beuran M, Bhalla A, Bhaumik S, Bhutta ZA, Biadgo B, Biffino M, Bijani A, Bililign N, Birungi C, Boufous S, Brazinova A, Brown AW, Car M, Cárdenas R, Carrero JJ, Carvalho F, Castañeda-Orjuela CA, Catalá-López F, Chaiah Y, Champs AP, Chang J-C, Choi J-YJ, Christopher DJ, Cooper C, Crowe CS, Dandona L, Dandona R, Daryani A, Davitoiu DV, Degefa MG, Demoz GT, Deribe K, Djalalinia S, Do HP, Doku DT, Drake TM, Dubey M, Dubljanin E, El-Khatib Z, Ofori-Asenso R, Eskandarieh S, Esteghamati A, Esteghamati S, Faro A, Farzadfar F, Farzaei MH, Fereshtehnejad S-M, Fernandes E, Feyissa GT, Filip I, Fischer F, Fukumoto T, Ganji M, Gankpe FG, Gebre AK, Gebrehiwot TT, Gezae KE, Gopalkrishna G, Goulart AC, Haagsma JA, Haj-Mirzaian A, Haj-Mirzaian A, Hamadeh RR, Hamidi S, Haro JM, Hassankhani H, Hassen HY, Havmoeller R, Hawley C, Hay SI, Hegazy MI, Hendrie D, Henok A, Hibstu DT, Hoffman HJ, Hole MK, Rad EH, Hosseini SM, Hostiuc S, Hu G, Hussen MA, Ilesanmi OS, Irvani SSN, Jakovljevic M, Jayaraman S, Jha RP, Jonas JB, Jones KM, Shushtari ZJ, Jozwiak JJ, Jürisson M, Kabir A, Kahsay A, Kahssay M, Kalani R, Karch A, Kasaeian A, Kassa GM, Kassa TD, Kassa ZY, Kengne AP, Khader YS, Khafaie MA, Khalid N, Khalil I, Khan EA, Khan MS, Khang Y-H, Khazaie H, Khoja AT, Khubchandani J, Kiadaliri AA, Kim D, Kim Y-E, Kisa A, Koyanagi A, Krohn KJ, Defo BK, Bicer BK, Kumar GA, Kumar M, Lalloo R, Lami FH, Lansingh VC, Laryea DO, Latifi A, Leshargie CT, Levi M, Li S, Liben ML, Lotufo PA, Lunevicius R, Mahotra NB, Majdan M, Majeed A, Malekzadeh R, Manda A-L, Mansournia MA, Massenburg BB, Mate KKV, Mehndiratta MM, Mehta V, Meles H, Melese A, Memiah PTN, Mendoza W, Mengistu G, Meretoja A, Meretoja TJ, Mestrovic T, Miazgowski T, Miller TR, Mini G, Mirica A, Mirrakhimov EM, Moazen B, Mohammadi M, Molokhia M, Monasta L, Mondello S, Moosazadeh M, Moradi G, Moradi M, Moradi-Lakeh M, Moradinazar M, Morrison SD, Moschos MM, Mousavi SM, Murthy S, Musa KI, Mustafa G, Naghavi M, Naik G, Najafi F, Nangia V, Nascimento BR, Negoi I, Nguyen TH, Nichols E, Ningrum DNA, Nirayo YL, Nyasulu PS, Ogbo FA, Oh I-H, Okoro A, Olagunju AT, Olagunju TO, Olivares PR, Otstavnov SS, Owolabi MO, Mahesh PA, Pakhale S, Pandey AR, Pesudovs K, Pinilla-Monsalve GD, Polinder S, Poustchi H, Prakash S, Qorbani M, Radfar A, Rafay A, Rafiei A, Rahimi-Movaghar A, Rahimi-Movaghar V, Rahman M, Rahman MA, Rai RK, Rajati F, Ram U, Rawaf DL, Rawaf S, Reiner RC, Reis C, Renzaho AMN, Resnikoff S, Rezaei S, Rezaeian S, Roever L, Ronfani L, Roshandel G, Roy N, Ruhago GM, Saddik B, Safari H, Safiri S, Sahraian MA, Salamati P, Saldanha RF, Samy AM, Sanabria J, Santos JV, Milicevic MMMS, Sartorius B, Satpathy M, Savuon K, Schneider IJC, Schwebel DC, Sepanlou SG, Shabaninejad H, Shaikh MAA, Shams-Beyranvand M, Sharif M, Sharif-Alhoseini M, Islam SMS, She J, Sheikh A, Shen J, Sheth KN, Shibuya K, Shiferaw MS, Shigematsu M, Shiri R, Shiue I, Shoman H, Siabani S, Siddiqi TJ, Silva JP, Silveira DGA, Sinha DN, Smith M, Filho AMS, Sobhani S, Soofi M, Soriano JB, Soyiri IN, Stein DJ, Stokes MA, Sufiyan MB, Sunguya BF, Sunshine JE, Sykes BL, Szoeke CEI, Tabarés-Seisdedos R, Ao BJT, Tehrani-Banihashemi A, Tekle MG, Temsah M-H, Temsah O, Topor-Madry R, Tortajada-Girbés M, Tran BX, Tran KB, Car LT, Ukwaja KN, Ullah I, Usman MS, Uthman OA, Valdez PR, Vasankari TJ, Venketasubramanian N, Violante FS, Wagnew FWS, Waheed Y, Wang Y-P, Weldegwergs KG, Werdecker A, Wijeratne T, Winkler AS, Wyper GMA, Yano Y, Yaseri M, Yasin YJ, Ye P, Yimer EM, Yip P, Yisma E, Yonemoto N, Yoon S-J, Yost MG, Younis MZ, Yousefifard M, Yu C, Zaidi Z, Zaman SB, Zamani M, Zenebe ZM, Zodpey S, Feigin VL, Vos T, Murray CJL (2019) Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol 18:56–87. https://doi.org/10.1016/S1474-4422(18)30415-0
Goff ZD, Kichura AB, Chibnall JT, Hauptman PJ (2017) A survey of unregulated direct-to-consumer treatment centers providing stem cells for patients with heart failure. JAMA Intern Med 177(9). https://doi.org/10.1001/jamainternmed.2017.2988
Goldman SA (2016) Stem and progenitor cell-based therapy of the central nervous system: hopes, hype, and wishful thinking. Cell Stem Cell. https://doi.org/10.1016/j.stem.2016.01.012
Gonzalez R, Hamblin MH, Lee J-P (2016) Neural stem cell transplantation and CNS diseases. CNS Neurol Disord Drug Targets 15:881–886
Gotherstrom C, Westgren M, Shaw SW, Astrom E, Biswas A, Byers PH, Mattar CN, Graham GE, Taslimi J, Ewald U, Fisk NM, Yeoh AE, Lin JL, Cheng PJ, Choolani M, Le Blanc K, Chan JK (2014) Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experience. Stem Cells Transl Med 3(2):255–264. https://doi.org/10.5966/sctm.2013-0090
Goutman SA, Brown MB, Glass JD, Boulis NM, Johe K, Hazel T, Cudkowicz M, Atassi N, Borges L, Patil PG, Sakowski SA, Feldman EL (2018) Long-term phase 1/2 intraspinal stem cell transplantation outcomes in ALS. Ann Clin Transl Neurol 5:730–740. https://doi.org/10.1002/acn3.567
Guenou H, Nissan X, Larcher F, Feteira J, Lemaitre G, Saidani M, Del Rio M, Barrault CC, Bernard FX, Peschanski M, Baldeschi C, Waksman G (2009) Human embryonic stem-cell derivatives for full reconstruction of the pluristratified epidermis: a preclinical study. Lancet 374(9703):1745–1753. https://doi.org/10.1016/S0140-6736(09)61496-3
Gupta RK, Abdul-Jawad S, McCoy LE, Mok HP, Peppa D, Salgado M, Martinez-Picado J, Nijhuis M, Wensing AMJ, Lee H, Grant P, Nastouli E, Lambert J, Pace M, Salasc F, Monit C, Innes AJ, Muir L, Waters L, Frater J, Lever AML, Edwards SG, Gabriel IH, Olavarria E (2019) HIV-1 remission following CCR5Delta32/Delta32 haematopoietic stem-cell transplantation. Nature 568(7751):244–248. https://doi.org/10.1038/s41586-019-1027-4
Gyurkocza B, Storb R, Storer BE, Chauncey TR, Lange T, Shizuru JA, Langston AA, Pulsipher MA, Bredeson CN, Maziarz RT, Bruno B, Petersen FB, Maris MB, Agura E, Yeager A, Bethge W, Sahebi F, Appelbaum FR, Maloney DG, Sandmaier BM (2010) Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia. J Clin Oncol 28(17):2859–2867. https://doi.org/10.1200/JCO.2009.27.1460
Hainzl S, Peking P, Kocher T, Murauer EM, Larcher F, Del Rio M, Duarte B, Steiner M, Klausegger A, Bauer JW, Reichelt J, Koller U (2017) COL7A1 editing via CRISPR/Cas9 in recessive dystrophic epidermolysis bullosa. Mol Ther 25(11):2573–2584. https://doi.org/10.1016/j.ymthe.2017.07.005
Henig I, Zuckerman T (2014) Hematopoietic stem cell transplantation-50 years of evolution and future perspectives. Rambam Maimonides Med J 5(4):e0028. https://doi.org/10.5041/RMMJ.10162
Hernon CA, Dawson RA, Freedlander E, Short R, Haddow DB, Brotherston M, MacNeil S (2006) Clinical experience using cultured epithelial autografts leads to an alternative methodology for transferring skin cells from the laboratory to the patient. Regen Med 1(6):809–821. https://doi.org/10.2217/17460751.1.6.809
Hirsch T, Rothoeft T, Teig N, Bauer JW, Pellegrini G, De Rosa L, Scaglione D, Reichelt J, Klausegger A, Kneisz D, Romano O, Secone Seconetti A, Contin R, Enzo E, Jurman I, Carulli S, Jacobsen F, Luecke T, Lehnhardt M, Fischer M, Kueckelhaus M, Quaglino D, Morgante M, Bicciato S, Bondanza S, De Luca M (2017) Regeneration of the entire human epidermis using transgenic stem cells. Nature 551(7680):327–332. https://doi.org/10.1038/nature24487
Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner MK (1999) Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 5(3):309–313. https://doi.org/10.1038/6529
Hu C, Zhao L, Li L (2019) Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases. Stem Cell Res Ther 10(1):199. https://doi.org/10.1186/s13287-019-1310-1
Igarashi P, Somlo S (2007) Polycystic kidney disease. J Am Soc Nephrol 18(5):1371–1373. https://doi.org/10.1681/ASN.2007030299
Iijima H, Isho T, Kuroki H, Takahashi M, Aoyama T (2018) Effectiveness of mesenchymal stem cells for treating patients with knee osteoarthritis: a meta-analysis toward the establishment of effective regenerative rehabilitation. NPJ Regen Med 3:15. https://doi.org/10.1038/s41536-018-0041-8
Inoue H, Nagata N, Kurokawa H, Yamanaka S (2014) iPS cells: a game changer for future medicine. EMBO J 33(5):409–417. https://doi.org/10.1002/embj.201387098
Iriguchi S, Kaneko S (2019) Toward the development of true “off-the-shelf” synthetic T-cell immunotherapy. Cancer Sci 110(1):16–22. https://doi.org/10.1111/cas.13892
Izmiryan A, Ganier C, Bovolenta M, Schmitt A, Mavilio F, Hovnanian A (2018) Ex vivo COL7A1 correction for recessive dystrophic epidermolysis bullosa using CRISPR/Cas9 and homology-directed repair. Mol Ther Nucleic Acids 12:554–567. https://doi.org/10.1016/j.omtn.2018.06.008
JCR Pharmaceuticals Co. L (2017) Annual Report. https://ssl4.eir-parts.net/doc/4552/ir_material_for_fiscal_ym4/63251/00.pdf
Jessop H, Farge D, Saccardi R, Alexander T, Rovira M, Sharrack B, Greco R, Wulffraat N, Moore J, Kazmi M, Badoglio M, Adams G, Verhoeven B, Murray J, Snowden JA (2019) General information for patients and carers considering haematopoietic stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): a position statement from the EBMT Autoimmune Diseases Working Party (ADWP), the EBMT Nurses Group, the EBMT Patient, Family and Donor Committee and the Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplant 54(7):933–942. https://doi.org/10.1038/s41409-019-0430-7
Jungbluth P, Spitzhorn LS, Grassmann J, Tanner S, Latz D, Rahman MS, Bohndorf M, Wruck W, Sager M, Grotheer V, Kropil P, Hakimi M, Windolf J, Schneppendahl J, Adjaye J (2019) Human iPSC-derived iMSCs improve bone regeneration in minipigs. Bone Res 7 (1):32. https://doi.org/10.1038/s41413-019-0069-4
Kalia LV, Lang AE (2015) Parkinson’s disease. Lancet (London, UK) 386:896–912. https://doi.org/10.1016/S0140-6736(14)61393-3
Karimkhani C, Dellavalle RP, Coffeng LE, Flohr C, Hay RJ, Langan SM, Nsoesie EO, Ferrari AJ, Erskine HE, Silverberg JI, Vos T, Naghavi M (2017) Global skin disease morbidity and mortality: an update from the global burden of disease study 2013. JAMA Dermatol 153(5):406–412. https://doi.org/10.1001/jamadermatol.2016.5538
Kharroubi AT, Darwish HM (2015) Diabetes mellitus: the epidemic of the century. World J Diabetes 6(6):850–867. https://doi.org/10.4239/wjd.v6.i6.850
Kim JH, Kurtz A, Yuan BZ, Zeng F, Lomax G, Loring JF, Crook J, Ju JH, Clarke L, Inamdar MS, Pera M, Firpo MT, Sheldon M, Rahman N, O’Shea O, Pranke P, Zhou Q, Isasi R, Rungsiwiwut R, Kawamata S, Oh S, Ludwig T, Masui T, Novak TJ, Takahashi T, Fujibuchi W, Koo SK, Stacey GN (2017) Report of the international stem cell banking initiative workshop activity: current hurdles and progress in seed-stock banking of human pluripotent stem cells. Stem Cells Transl Med 6(11):1956–1962. https://doi.org/10.1002/sctm.17-0144
Klein J, Sato A (2000) The HLA system. N Engl J Med 434(10):702–709. https://doi.org/10.1056/NEJM200009073431006
Kobayashi K, Stamm C, Nakauchi A (2019) First iPSC-Derived CAR T-Cell Therapy Created by Kyoto University CiRA and Takeda Collaboration Enters Process Development Toward Clinical Testing. https://www.takeda.com/newsroom/newsreleases/2019/first-ipsc-derived-car-t-cell-therapy-created-by-kyoto-university-cira-and%2D%2Dtakeda-collaboration-enters-process-development-toward-clinical-testing/. Accessed 6 Sept 2019
Kurtzberg J, Prockop S, Teira P, Bittencourt H, Lewis V, Chan KW, Horn B, Yu L, Talano JA, Nemecek E, Mills CR, Chaudhury S (2014) Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. Biol Blood Marrow Transplant 20(2):229–235. https://doi.org/10.1016/j.bbmt.2013.11.001
Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI (1995) Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 16(4)
Little MT, Storb R (2002) History of haematopoietic stem-cell transplantation. Nat Rev Cancer 2(3):231–238. https://doi.org/10.1038/nrc748
Makhlough A, Shekarchian S, Moghadasali R, Einollahi B, Hosseini SE, Jaroughi N, Bolurieh T, Baharvand H, Aghdami N (2017) Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients. Stem Cell Res Ther 8(1):116. https://doi.org/10.1186/s13287-017-0557-7
Malliaras K, Makkar RR, Smith RR, Cheng K, Wu E, Bonow RO, Marbán L, Mendizabal A, Cingolani E, Johnston PV, Gerstenblith G, Schuleri KH, Lardo AC, Marbán E (2014) Intracoronary cardiosphere-derived cells after myocardial infarction. J Am Coll Cardiol 63(2):110–122. https://doi.org/10.1016/j.jacc.2013.08.724
Marks PW, Witten CM, Califf RM (2017) Clarifying stem-cell Therapy’s benefits and risks. N Engl J Med 376(11):1007–1009. https://doi.org/10.1056/NEJMp1613723
Mavilio F, Pellegrini G, Ferrari S, Di Nunzio F, Di Iorio E, Recchia A, Maruggi G, Ferrari G, Provasi E, Bonini C, Capurro S, Conti A, Magnoni C, Giannetti A, De Luca M (2006) Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nat Med 12(12):1397–1402. https://doi.org/10.1038/nm1504
Maximow AA (1924) Relation of blood cells to connective tissues and endothelium. Physiol Rev 4(4):533–563. https://doi.org/10.1152/physrev.1924.4.4.533
Menasche P, Vanneaux V, Hagege A, Bel A, Cholley B, Parouchev A, Cacciapuoti I, Al-Daccak R, Benhamouda N, Blons H, Agbulut O, Tosca L, Trouvin JH, Fabreguettes JR, Bellamy V, Charron D, Tartour E, Tachdjian G, Desnos M, Larghero J (2018) Transplantation of human embryonic stem cell-derived cardiovascular progenitors for severe ischemic left ventricular dysfunction. J Am Coll Cardiol 71(4):429–438. https://doi.org/10.1016/j.jacc.2017.11.047
Michler RE (2018) The current status of stem cell therapy in ischemic heart disease. J Card Surg 33(9):520–531. https://doi.org/10.1111/jocs.13789
Ming G, Song H (2011) Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron. https://doi.org/10.1016/j.neuron.2011.05.001
Nagoshi N, Tsuji O, Nakamura M, Okano H (2019) Cell therapy for spinal cord injury using induced pluripotent stem cells. Regen Ther 11:75–80. https://doi.org/10.1016/J.RETH.2019.05.006
O’Connor NE, Mulliken JB (1981) Grafting of burns with cultured epithelium prepared from autologous epidermal cells. Lancet 1(8211):75–78
Oh KW, Moon C, Kim HY, Oh SI, Park J, Lee JH, Chang IY, Kim KS, Kim SH (2015) Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis. Stem Cells Transl Med 4(6):590–597. https://doi.org/10.5966/sctm.2014-0212
Panch SR, Szymanski J, Savani BN, Stroncek DF (2017) Sources of hematopoietic stem and progenitor cells and methods to optimize yields for clinical cell therapy. Biol Blood Marrow Transplant 23(8):1241–1249. https://doi.org/10.1016/j.bbmt.2017.05.003
Panés J, García-Olmo D, Van Assche G, Colombel JF, Reinisch W, Baumgart DC, Dignass A, Nachury M, Ferrante M, Kazemi-Shirazi L, Grimaud JC, de la Portilla F, Goldin E, Richard MP, Leselbaum A, Danese S (2016) Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn’s disease: a phase 3 randomised, double-blind controlled trial. Lancet 388(10051):1281–1290. https://doi.org/10.1016/s0140-6736(16)31203-x
Passweg JR, Baldomero H, Basak GW, Chabannon C, Corbacioglu S, Duarte R, Kuball J, Lankester A, Montoto S, de Latour RP, Snowden JA, Styczynski J, Yakoub-Agha I, Arat M, Mohty M, Kroger N, European Society for B, Marrow T (2019) The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transplant. https://doi.org/10.1038/s41409-019-0465-9
Pellegrini G, Rama P, Mavilio F, De Luca M (2009) Epithelial stem cells in corneal regeneration and epidermal gene therapy. J Pathol 217(2):217–228. https://doi.org/10.1002/path.2441
Pereira IM, Marote A, Salgado AJ, Silva NA (2019) Filling the gap: neural stem cells as a promising therapy for spinal cord injury. Pharmaceuticals (Basel, Switzerland) 12. https://doi.org/10.3390/ph12020065
Petrof G, Abdul-Wahab A, McGrath JA (2014) Cell therapy in dermatology. Cold Spring Harb Perspect Med 4(6). https://doi.org/10.1101/cshperspect.a015156
Petrof G, Lwin SM, Martinez-Queipo M, Abdul-Wahab A, Tso S, Mellerio JE, Slaper-Cortenbach I, Boelens JJ, Tolar J, Veys P, Ofuya M, Peacock JL, Martinez AE, McGrath JA (2015) Potential of systemic allogeneic mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 135(9):2319–2321. https://doi.org/10.1038/jid.2015.158
Pullen LC (2018) Stem cell-derived pancreatic progenitor cells have now been transplanted into patients: report from IPITA 2018. Am J Transplant 18(7):1581–1582. https://doi.org/10.1111/ajt.14954
Rahman MS, Spitzhorn L-S, Wruck W, Hagenbeck C, Balan P, Graffmann N, Bohndorf M, Ncube A, Guillot PV, Fehm T, Adjaye J (2018) The presence of human mesenchymal stem cells of renal origin in amniotic fluid increases with gestational time. Stem Cell Res Ther 9(1). https://doi.org/10.1186/s13287-018-0864-7
Rama P, Matuska S, Paganoni G, Spinelli A, De Luca M, Pellegrini G (2010) Limbal stem-cell therapy and long-term corneal regeneration. N Engl J Med 363(2):147–155. https://doi.org/10.1056/NEJMoa0905955
Rheinwald JG, Green H (1975) Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6(3):331–343. https://doi.org/10.1016/s0092-8674(75)80001-8
Sakai D, Schol J, Foldager CB, Sato M, Watanabe M (2017) Regenerative technologies to bed side: evolving the regulatory framework. J Orthop Translat 9:1–7. https://doi.org/10.1016/j.jot.2017.02.001
Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Werner N, Haase J, Neuzner J, Germing A, Mark B, Assmus B, Tonn T, Dimmeler S, Zeiher AM (2006) Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 27(23):2775–2783. https://doi.org/10.1093/eurheartj/ehl388
Schwartz SD, Regillo CD, Lam BL, Eliott D, Rosenfeld PJ, Gregori NZ, Hubschman J-P, Davis JL, Heilwell G, Spirn M, Maguire J, Gay R, Bateman J, Ostrick RM, Morris D, Vincent M, Anglade E, Del Priore LV, Lanza R (2015) Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt’s macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet 385:509–516. https://doi.org/10.1016/S0140-6736(14)61376-3
Seaberg RM, van der Kooy D (2003) Stem and progenitor cells: the premature desertion of rigorous definitions. Trends Neurosci 26:125–131. https://doi.org/10.1016/S0166-2236(03)00031-6
Sebastiano V, Zhen HH, Haddad B, Bashkirova E, Melo SP, Wang P, Leung TL, Siprashvili Z, Tichy A, Li J, Ameen M, Hawkins J, Lee S, Li L, Schwertschkow A, Bauer G, Lisowski L, Kay MA, Kim SK, Lane AT, Wernig M, Oro AE (2014) Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa. Sci Transl Med 6(264):264ra163. https://doi.org/10.1126/scitranslmed.3009540
Segers VFM, Lee RT (2008) Stem-cell therapy for cardiac disease. Nature 451(7181):937–942. https://doi.org/10.1038/nature06800
Sheyn D, Ben-David S, Shapiro G, De Mel S, Bez M, Ornelas L, Sahabian A, Sareen D, Da X, Pelled G, Tawackoli W, Liu Z, Gazit D, Gazit Z (2016) Human induced pluripotent stem cells differentiate into functional mesenchymal stem cells and repair bone defects. Stem Cells Transl Med 5(11):1447–1460. https://doi.org/10.5966/sctm.2015-0311
Sipp D, Caulfield T, Kaye J, Barfoot J, Blackburn C, Chan S, De Luca M, Kent A, McCabe C, Munsie M, Sleeboom-Faulkner M, Sugarman J, van Zimmeren E, Zarzeczny A, Rasko JEJ (2017) Marketing of unproven stem cell-based interventions: a call to action. Sci Transl Med 9(397). https://doi.org/10.1126/scitranslmed.aag0426
Smets F, Dobbelaere D, McKiernan P, Dionisi-Vici C, Broue P, Jacquemin E, Lopes AI, Goncalves I, Mandel H, Pawlowska J, Kaminska D, Shteyer E, Torre G, Shapiro R, Eyskens F, Clapuyt P, Gissen P, Pariente D, Grunewald S, Yudkoff M, Binda MM, Najimi M, Belmonte N, Vos B, Thonnard J, Sokal E (2019) Phase I/II trial of liver derived mesenchymal stem cells in pediatric liver based metabolic disorders: a prospective, open label, multicenter, partially randomized, safety study of one cycle of heterologous human adult liver-derived progenitor cells (HepaStem(R)) in urea cycle disorders and Crigler-Najjar Syndrome patients. Transplantation. https://doi.org/10.1097/TP.0000000000002605
Sneddon JB, Tang Q, Stock P, Bluestone JA, Roy S, Desai T, Hebrok M (2018) Stem cell therapies for treating diabetes: progress and remaining challenges. Cell Stem Cell 22(6):810–823. https://doi.org/10.1016/j.stem.2018.05.016
Sokal EM (2014) Treating inborn errors of liver metabolism with stem cells: current clinical development. J Inherit Metab Dis 37(4):535–539. https://doi.org/10.1007/s10545-014-9691-x
Sokal EM, Stephenne X, Ottolenghi C, Jazouli N, Clapuyt P, Lacaille F, Najimi M, de Lonlay P, Smets F (2014) Liver engraftment and repopulation by in vitro expanded adult derived human liver stem cells in a child with ornithine carbamoyltransferase deficiency. JIMD Rep 13:65–72. https://doi.org/10.1007/8904_2013_257
Spitzhorn L-S, Rahman MS, Schwindt L, Ho H-T, Wruck W, Bohndorf M, Wehrmeyer S, Ncube A, Beyer I, Hagenbeck C, Balan P, Fehm T, Adjaye J (2017) Isolation and molecular characterization of amniotic fluid-derived mesenchymal stem cells obtained from caesarean sections. Stem Cells Int 2017:1–15. https://doi.org/10.1155/2017/5932706
Spitzhorn LS, Kordes C, Megges M, Sawitza I, Gotze S, Reichert D, Schulze-Matz P, Graffmann N, Bohndorf M, Wruck W, Kohler JP, Herebian D, Mayatepek E, Oreffo RO, Haussinger D, Adjaye J (2018) Transplanted human pluripotent stem cell-derived mesenchymal stem cells support liver regeneration in Gunn rats. Stem Cells Dev. https://doi.org/10.1089/scd.2018.0010
Spitzhorn LS, Megges M, Wruck W, Rahman MS, Otte J, Degistirici O, Meisel R, Sorg RV, Oreffo ROC, Adjaye J (2019) Human iPSC-derived MSCs (iMSCs) from aged individuals acquire a rejuvenation signature. Stem Cell Res Ther 10(1):100. https://doi.org/10.1186/s13287-019-1209-x
Stanger BZ (2015) Cellular homeostasis and repair in the mammalian liver. Annu Rev Physiol 77:179–200. https://doi.org/10.1146/annurev-physiol-021113-170255
Steinhoff G, Nesteruk J, Wolfien M, Kundt G, Börgermann J, David R, Garbade J, Große J, Haverich A, Hennig H, Kaminski A, Lotz J, Mohr F-W, Müller P, Oostendorp R, Ruch U, Sarikouch S, Skorska A, Stamm C, Tiedemann G, Wagner FM, Wolkenhauer O (2017) Cardiac function improvement and bone marrow response –. EBioMedicine 22:208–224. https://doi.org/10.1016/j.ebiom.2017.07.022
Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5):861–872. https://doi.org/10.1016/j.cell.2007.11.019
Tang Y, Yu P, Cheng L (2017) Current progress in the derivation and therapeutic application of neural stem cells. Nat Publ Group 8:3108. https://doi.org/10.1038/cddis.2017.504
Thomas ED, Lochte HL Jr, Lu WC, Ferrebee JW (1957) Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 257(11):491–496. https://doi.org/10.1056/NEJM195709122571102
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM (1998) Embryonic stem cell lines derived from human blastocysts. Science 282(5391):1145–1147
Tolar J, McGrath JA, Xia L, Riddle MJ, Lees CJ, Eide C, Keene DR, Liu L, Osborn MJ, Lund TC, Blazar BR, Wagner JE (2014) Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa. J Invest Dermatol 134(5):1246–1254. https://doi.org/10.1038/jid.2013.523
Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD (2002) Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105(1):93–98. https://doi.org/10.1161/hc0102.101442
Tsuji O, Sugai K, Yamaguchi R, Tashiro S, Nagoshi N, Kohyama J, Iida T, Ohkubo T, Itakura G, Isoda M, Shinozaki M, Fujiyoshi K, Kanemura Y, Yamanaka S, Nakamura M, Okano H (2019) Concise review: laying the groundwork for a first-in-human study of an induced pluripotent stem cell-based intervention for spinal cord injury. Stem Cells 37:6–13. https://doi.org/10.1002/stem.2926
Tysnes O-B, Storstein A (2017) Epidemiology of Parkinson’s disease. J Neural Transm 124:901–905. https://doi.org/10.1007/s00702-017-1686-y
van Rood JJ (1966) Leucocyte groups and histocompatibility. Vox Sang 11(3):276–292. https://doi.org/10.1111/j.1423-0410.1966.tb04603.x
Wenker SD, Pitossi FJ (2019) Cell therapy for Parkinson’s disease is coming of age: current challenges and future prospects with a focus on immunomodulation. Gene Ther. https://doi.org/10.1038/s41434-019-0077-4
Wenzel D, Bayerl J, Nystrom A, Bruckner-Tuderman L, Meixner A, Penninger JM (2014) Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa. Sci Transl Med 6(264):264ra165. https://doi.org/10.1126/scitranslmed.3010083
Wu M, Zhang R, Zou Q, Chen Y, Zhou M, Li X, Ran R, Chen Q (2018) Comparison of the biological characteristics of mesenchymal stem cells derived from the human placenta and umbilical cord. Sci Rep 8(1):5014. https://doi.org/10.1038/s41598-018-23396-1
Yang YK (2018) Aging of mesenchymal stem cells: implication in regenerative medicine. Regen Ther 9:120–122. https://doi.org/10.1016/j.reth.2018.09.002
Zhao Y, Jiang Z, Zhao T, Ye M, Hu C, Zhou H, Yin Z, Chen Y, Zhang Y, Wang S, Shen J, Thaker H, Jain S, Li Y, Diao Y, Chen Y, Sun X, Fisk MB, Li H (2013) Targeting insulin resistance in type 2 diabetes via immune modulation of cord blood-derived multipotent stem cells (CB-SCs) in stem cell educator therapy: phase I/II clinical trial. BMC Med 11:160. https://doi.org/10.1186/1741-7015-11-160
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this entry
Cite this entry
Graffmann, N., Spitzhorn, LS., Martins, S., Rahman, M.S., Nguyen, L., Adjaye, J. (2020). Stem Cell Therapy. In: Hock, F., Gralinski, M. (eds) Drug Discovery and Evaluation: Methods in Clinical Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-319-56637-5_72-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-56637-5_72-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-56637-5
Online ISBN: 978-3-319-56637-5
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences